The minimal set of genetic alterations required for conversion of primary human fibroblasts to cancer cells in the subrenal capsule assay.
about
Telomerase and the aging processInTERTesting association between telomerase, mTOR and phytochemicalsA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingThe therapeutic promise of the cancer stem cell concept.Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.Identification and targeting of cancer stem cells.Assessment of transformed properties in vitro and of tumorigenicity in vivo in primary keratinocytes cultured for epidermal sheet transplantation.Towards a more functional concept of causality in cancer researchImproving cell therapy--experiments using transplanted telomerase-immortalized cells in immunodeficient miceFibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect.Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.Short telomeres: cause or consequence of aging?Resistance to experimental tumorigenesis in cells of a long-lived mammal, the naked mole-rat (Heterocephalus glaber).Fibroblasts from Werner syndrome patients: cancer cells derived by experimental introduction of oncogenes maintain malignant properties despite entering crisis.Cellular aging and cancer.High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.Neoplasia: An Anniversary of Progress.
P2860
Q24684063-1756610A-EE97-42B1-878B-15D87A786201Q28262993-425BD982-6281-4CFC-A7AA-E5629F3BFA8BQ28389391-A251C481-275F-4080-AA90-BA40500DDE4AQ28395095-DE479AC0-BB48-49FB-977B-35AD6B46F655Q33559711-9C05DE8F-4E9C-4087-BAD7-29A504C25ACAQ33822831-97DA6AE4-70BD-4FB0-ADE2-5BF3DEE79ECCQ33921460-0F191A28-9FC5-42E9-915A-535AB12039A7Q34415161-2FF8237D-B2D3-46BF-AFEB-0BDBC7E58199Q34793895-8A5210E8-650B-4B40-8AAB-27FE7DD4C7D3Q35636411-E3359EFB-F153-485F-B69E-AA6A81500C02Q35812731-D79D8A5A-4270-4E29-91D4-4867C7A11A1AQ36090294-C4A19FB0-B30E-4AAF-BC19-DE489D514A31Q36642786-E0EBAF23-D452-46B1-8388-3EB2D98237B5Q37094804-BEE61982-7197-451A-86E9-A0ECDDA57A31Q37094815-EE323FA2-90D3-4D9F-AA0D-49BE1B580D72Q37779657-AC4802AE-7DDC-4F7F-98ED-D6BAD378EC03Q39804025-98604E69-9B48-4743-BD66-BF50DE77DDD2Q46932476-BB3BC375-211C-4229-B2BB-4EAEB6907B20
P2860
The minimal set of genetic alterations required for conversion of primary human fibroblasts to cancer cells in the subrenal capsule assay.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The minimal set of genetic alt ...... in the subrenal capsule assay.
@ast
The minimal set of genetic alt ...... in the subrenal capsule assay.
@en
The minimal set of genetic alt ...... in the subrenal capsule assay.
@nl
type
label
The minimal set of genetic alt ...... in the subrenal capsule assay.
@ast
The minimal set of genetic alt ...... in the subrenal capsule assay.
@en
The minimal set of genetic alt ...... in the subrenal capsule assay.
@nl
prefLabel
The minimal set of genetic alt ...... in the subrenal capsule assay.
@ast
The minimal set of genetic alt ...... in the subrenal capsule assay.
@en
The minimal set of genetic alt ...... in the subrenal capsule assay.
@nl
P2093
P2860
P356
P1433
P1476
The minimal set of genetic alt ...... in the subrenal capsule assay.
@en
P2093
Beicheng Sun
Christina L Hawks
Meizhen Chen
Olivia M Pereira-Smith
Peter J Hornsby
P2860
P304
P356
10.1593/NEO.05172
P577
2005-06-01T00:00:00Z